Farmak International Receives Marketing Authorizations for Gadobutrol in Europe
Farmak International reports that marketing authorizations (MAs) have been granted for Gadobutrol in three European markets.
Here you will find the latest updates and news from Farmak International. Discover important announcements, breakthroughs in research, and developments in our ongoing commitment to advancing healthcare. Stay informed about our milestones as we continue to make a positive impact on global health.
Farmak International reports that marketing authorizations (MAs) have been granted for Gadobutrol in three European markets.
23 launches across Europe, MEA, and SEA, representing 19 products in key therapeutic areas
The collaboration formalizes a distribution framework that combines Farmak International’s portfolio expertise with UNIMED’s local supply chain capabilities.
Farmak International announces a new distribution partnership with Oxford Pharmacy Store (OPS) to expand access to its contrast media portfolio throughout the United Kingdom.
Please check your email inbox for our corporate materials.
OK, Got ItPlease fill all the fields marked by *